Novant Health Activates Sites for COVID-19 Anti-Viral Study in Record Time: Can Leronlimab Help SARS-CoV-2 Patients?

Novant Health Activates Sites for COVID-19 Anti-Viral Study in Record Time: Can Leronlimab Help SARS-CoV-2 Patients?

Novant Health will be one of the first clinical investigational sites to study whether a medication called leronlimab could be used to treat SARS-CoV-2, the virus behind the COVID-19 pandemic. Previously, leronlimab has been used in combination with medications to...
Stanford Shatters Record for Study Start-up For NIH COVID-19 Study Investigating Remdesivir

Stanford Shatters Record for Study Start-up For NIH COVID-19 Study Investigating Remdesivir

Stanford University moved quickly to ramp up the Gilead remdesivir global clinical trial—and enrolled 30 participants quickly thereafter for the adaptive clinical trial. And the elite San Francisco Bay Area academic medical center recently began enrolling patients in...

Pin It on Pinterest